Abstract
Renal sympathetic denervation (RDN) has, until recently, been a black box procedure, driven by incomplete knowledge on the anatomy of the sympathetic nervous system. In recent years, several procedural advancements have been made. The distribution of sympathetic nerves in the relation to the renal arteries has been further analyzed. The impact of different lesion sites, lesion numbers, and patterns has been evaluated. The spectrum of denervation techniques and systems has been expanded and adjusted according to new anatomical findings. In addition, possibilities of intra-procedural efficacy evaluation are being developed. The following chapter summarizes our current knowledge and recent developments on procedural aspects of renal denervation. It then outlines steps prior, during, and post procedure with instructions on the commercially available renal denervation systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BP:
-
Blood pressure
- HTN:
-
Hypertension
- RDN:
-
Renal denervation
References
Ozkan U, Oguzkurt L, Tercan F, Kizilkilic O, Koc Z, Koca N (2006) Renal artery origins and variations: angiographic evaluation of 855 consecutive patients. Diagn Interv Radiol 12(4):183–186
Turba UC, Uflacker R, Bozlar U, Hagspiel KD (2009) Normal renal arterial anatomy assessed by multidetector CT angiography: are there differences between men and women? Clin Anat 22(2):236–242. doi:10.1002/ca.20748
Manso JC, DiDio LJ (2000) Anatomical variations of the human suprarenal arteries. Ann Anat 182(5):483–488. doi:10.1016/S0940-9602(00)80064-3
Tsioufis C, Mahfoud F, Mancia G, Redon J, Damascelli B, Zeller T, Schmieder RE (2014) What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention 9(9):1027–1035. doi:10.4244/EIJV9I9A175
Esler M (2015) The sympathetic nervous system in hypertension: back to the future? Curr Hypertens Rep 17(2):11. doi:10.1007/s11906-014-0519-8
Tellez A, Rousselle S, Palmieri T, Rate WR, Wicks J, Degrange A, Hyon CM, Gongora CA, Hart R, Grundy W, Kaluza GL, Granada JF (2013) Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies. Transl Res 162(6):381–389. doi:10.1016/j.trsl.2013.07.002
Atherton DS, Deep NL, Mendelsohn FO (2012) Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 25(5):628–633. doi:10.1002/ca.21280
Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR, Kolodgie FD, Virmani R, Joner M (2014) Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 64(7):635–643. doi:10.1016/j.jacc.2014.03.059
Mahfoud F, Edelman ER, Böhm M (2014) Catheter-based renal denervation is no simple matter: lessons to be learned from our anatomy? J Am Coll Cardiol 64(7):644–646. doi:10.1016/j.jacc.2014.05.037
Mahfoud F, Tunev S, Ewen S, Cremers B, Ruwart J, Schulz-Jander D, Linz D, Davies J, Kandzari DE, Whitbourn R, Böhm M, Melder RJ (2015) Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J Am Coll Cardiol 66(16):1766–1775. doi:10.1016/j.jacc.2015.08.018
Tzafriri AR, Mahfoud F, Keating JH, Markham PM, Spognardi A, Wong G, Fuimaono K, Böhm M, Edelman ER (2014) Innervation patterns may limit response to endovascular renal denervation. J Am Coll Cardiol 64(11):1079–1087. doi:10.1016/j.jacc.2014.07.937
Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S et al (2015) Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 36(4):219–227. doi:10.1093/eurheartj/ehu441
Rosa J, Widimsky P, Tousek P, Petrak O, Curila K, Waldauf P, Bednar F, Zelinka T, Holaj R, Strauch B, Somloova Z, Taborsky M, Vaclavik J, Kocianova E, Branny M et al (2015) Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Hypertension 65(2):407–413. doi:10.1161/HYPERTENSIONAHA.114.04019
Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C (2013) Does renal artery supply indicate treatment success of renal denervation? Cardiovasc Intervent Radiol 36(4):987–991. doi:10.1007/s00270-013-0652-9
Id D, Kaltenbach B, Bertog SC, Hornung M, Hofmann I, Vaskelyte L, Sievert H (2013) Does the presence of accessory renal arteries affect the efficacy of renal denervation? JACC Cardiovasc Interv 6(10):1085–1091. doi:10.1016/j.jcin.2013.06.007
Kandzari DE, Kario K, Mahfoud F, Cohen SA, Pilcher G, Pocock S, Townsend R, Weber MA, Böhm M (2016) The SPYRAL HTN global clinical trial program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J 171(1):82–91. doi:10.1016/j.ahj.2015.08.021
Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281. doi:10.1016/S0140-6736(09)60566-3
Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909. doi:10.1016/S0140-6736(10)62039-9
Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL et al (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393–1401. doi:10.1056/NEJMoa1402670
Patel HC, Dhillon PS, Mahfoud F, Lindsay AC, Hayward C, Ernst S, Lyon AR, Rosen SD, di Mario C (2014) The biophysics of renal sympathetic denervation using radiofrequency energy. Clin Res Cardiol 103(5):337–344. doi:10.1007/s00392-013-0618-6
Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V (2013) Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 34(28):2132–2140. doi:10.1093/eurheartj/eht197
Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard JM, Fajadet J, Mahfoud F (2015) Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity. EuroIntervention 11(4):477–484. doi:10.4244/EIJV11I4A96
Gertner M, Crura F, Zhang J (2015) Renal denervation using externally delivered focused ultrasound: summary of clinical experience to date and validation of supporting computational simulations. J Ther Ultrasound 3(Suppl 1):O68. doi:10.1186/2050-5736-3-S1-O68
Fischell TA, Fischell DR, Ghazarossian VE, Vega F, Ebner A (2015) Next generation renal denervation: chemical “perivascular” renal denervation with alcohol using a novel drug infusion catheter. Cardiovasc Revasc Med 16(4):221–227. doi:10.1016/j.carrev.2015.04.008
Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH et al (2013) International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol 62(22):2031–2045. doi:10.1016/j.jacc.2013.08.1616
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219. doi:10.1093/eurheartj/eht151
Persu A, Jin Y, Baelen M, Vink E, Verloop WL, Schmidt B, Blicher MK, Severino F, Wuerzner G, Taylor A, Pechere-Bertschi A, Jokhaji F, Fadl Elmula FE, Rosa J, Czarnecka D et al (2014) Eligibility for renal denervation: experience at 11 European expert centers. Hypertension 63(6):1319–1325. doi:10.1161/HYPERTENSIONAHA.114.03194
Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G, Investigators GSR (2015) First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension 65(4):766–774. doi:10.1161/HYPERTENSIONAHA.114.05010
Desch S, Okon T, Heinemann D, Kulle K, Rohnert K, Sonnabend M, Petzold M, Muller U, Schuler G, Eitel I, Thiele H, Lurz P (2015) Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension 65(6):1202–1208. doi:10.1161/HYPERTENSIONAHA.115.05283
Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Vehier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF et al (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385(9981):1957–1965. doi:10.1016/S0140-6736(14)61942-5
Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE (2015) Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension. J Hypertens 33(6):1261–1266. doi:10.1097/HJH.0000000000000556
Ribichini F, Ferrara A, Pighi M, Pesarini G, Gambaro A, Valvo E, Lupo A, Vassanelli C (2014) Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient. J Nephrol. doi:10.1007/s40620-014-0059-y
Rountas C, Vlychou M, Vassiou K, Liakopoulos V, Kapsalaki E, Koukoulis G, Fezoulidis IV, Stefanidis I (2007) Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail 29(3):295–302. doi:10.1080/08860220601166305
Mahfoud F, Tunev S, Ruwart J, Schulz-Jander D, Cremers B, Linz D, Zeller T, Bhatt DL, Rocha-Singh K, Böhm M, Melder RJ (2014) Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries. Circ Cardiovasc Interv 7(6):813–820. doi:10.1161/CIRCINTERVENTIONS.114.001506
Ziegler AK, Franke J, Bertog SC (2013) Renal denervation in a patient with prior renal artery stenting. Catheter Cardiovasc Interv 81(2):342–345. doi:10.1002/ccd.24507
Templin C, Jaguszewski M, Ghadri JR, Sudano I, Gaehwiler R, Hellermann JP, Schoenenberger-Berzins R, Landmesser U, Erne P, Noll G, Luscher TF (2013) Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter. Eur Heart J 34(28):2141–2148, 2148b. doi:10.1093/eurheartj/eht141
Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, Furuta Y, Aizawa Y, Iwafuchi M (2013) Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension 61(2):450–456. doi:10.1161/HYPERTENSIONAHA.111.00095
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zivanovic, I., Ewen, S., Böhm, M., Mahfoud, F. (2016). Procedural Aspects of Renal Sympathetic Denervation. In: Tsioufis, C., Schmieder, R., Mancia, G. (eds) Interventional Therapies for Secondary and Essential Hypertension. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-34141-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-34141-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34140-8
Online ISBN: 978-3-319-34141-5
eBook Packages: MedicineMedicine (R0)